Mechanisms of self-resistance in the Platensimycin- and platencin-producing streptomyces platensis MA7327 and MA7339 strains

Chemistry and Biology

Volumn 21, Issue 3, 2014, Pages 389-397

  Peterson, Ryan M ^a   Huang, Tingting ^b   Rudolf, Jeffrey D ^b   Smanski, Michael J ^a   Shen, Ben ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CITRATE SYNTHASE; CYSTEINE; PLATENCIN; PLATENSIMYCIN; UNCLASSIFIED DRUG; ADAMANTANE; AMINOBENZOIC ACID DERIVATIVE; AMINOPHENOL DERIVATIVE; ANILIDE; BACTERIAL PROTEIN; FATTY ACID SYNTHASE; POLYCYCLIC HYDROCARBON;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; DELETION MUTANT; FATTY ACID SYNTHESIS; GROWTH INHIBITION; HOUSEKEEPING GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERIZATION; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; STREPTOMYCES; STREPTOMYCES ALBUS; STREPTOMYCES AVERMITILIS; STREPTOMYCES COELICOLOR; STREPTOMYCES LIVIDANS; STREPTOMYCES PLATENSIS; STRUCTURAL BIOINFORMATICS; AMINO ACID SUBSTITUTION; BIOSYNTHESIS; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; MOLECULAR GENETICS; MULTIGENE FAMILY;

BACTERIA (MICROORGANISMS); STREPTOMYCES PLATENSIS;

ADAMANTANE; AMINO ACID SUBSTITUTION; AMINOBENZOATES; AMINOPHENOLS; ANILIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; DRUG RESISTANCE, BACTERIAL; FATTY ACID SYNTHASE, TYPE II; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; POLYCYCLIC COMPOUNDS; STREPTOMYCES;

EID: 84897088964     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2014.01.005     Document Type: Article

References (44)

1. A.W. Alberts, R.M. Bell, and P.R. Vagelos Acyl carrier protein. XV. Studies of -ketoacyl-acyl carrier protein synthetase J. Biol. Chem. 247 1972 3190 3198
2. W. Balemans, N. Lounis, R. Gilissen, J. Guillemont, K. Simmen, K. Andries, and A. Koul Essentiality of FASII pathway for Staphylococcus aureus Nature 463 2010 E3 E4 discussion E4
3. R. Benveniste, and J. Davies Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria Proc. Natl. Acad. Sci. USA 70 1973 2276 2280
4. M. Bierman, R. Logan, K. O'Brien, E.T. Seno, R.N. Rao, and B.E. Schoner Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp Gene 116 1992 43 49
5. S. Brinster, G. Lamberet, B. Staels, P. Trieu-Cuot, A. Gruss, and C. Poyart Type II fatty acid synthesis is not a suitable antibiotic target for gram-positive pathogens Nature 458 2009 83 86
6. S. Brinster, G. Lamberet, B. Staels, P. Trieu-Cuot, A. Gruss, and C. Poyart Essentiality of FASII pathway for Staphlococcus aureus Nature 463 2010 E3 E4
7. V.M. D'Costa, K.M. McGrann, D.W. Hughes, and G.D. Wright Sampling the antibiotic resistome Science 311 2006 374 377
8. U. Galm, M.H. Hager, S.G. Van Lanen, J. Ju, J.S. Thorson, and B. Shen Antitumor antibiotics: bleomycin, enediynes, and mitomycin Chem. Rev. 105 2005 739 758
9. B. Gust, G.L. Challis, K. Fowler, T. Kieser, and K.F. Chater PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin Proc. Natl. Acad. Sci. USA 100 2003 1541 1546
10. S.N. Ho, H.D. Hunt, R.M. Horton, J.K. Pullen, and L.R. Pease Site-directed mutagenesis by overlap extension using the polymerase chain reaction Gene 77 1989 51 59
11. D.A. Hopwood How do antibiotic-producing bacteria ensure their self-resistance before antibiotic biosynthesis incapacitates them? Mol. Microbiol. 63 2007 937 940
12. W. Huang, J. Jia, P. Edwards, K. Dehesh, G. Schneider, and Y. Lindqvist Crystal structure of β-ketoacyl-acyl carrier protein synthase II from E.coli reveals the molecular architecture of condensing enzymes EMBO J. 17 1998 1183 1191
13. T. Kieser, M.J. Bibb, M.J. Buttner, K.F. Chater, and D.A. Hopwood Practical Streptomyces Genetics 2000 The John Innes Foundation Norwich, UK
14. A. Kumar, and H.P. Schweizer Bacterial resistance to antibiotics: active efflux and reduced uptake Adv. Drug Deliv. Rev. 57 2005 1486 1513
15. P. Kursula, J. Ojala, A.-M. Lambeir, and R.K. Wierenga The catalytic cycle of biosynthetic thiolase: a conformational journey of an acetyl group through four binding modes and two oxyanion holes Biochemistry 41 2002 15543 15556
16. C.-Y. Lai, and J.E. Cronan β-ketoacyl-acyl carrier protein synthase III (FabH) is essential for bacterial fatty acid synthesis J. Biol. Chem. 278 2003 51494 51503
17. Y. Li, G. Florova, and K.A. Reynolds Alteration of the fatty acid profile of Streptomyces coelicolor by replacement of the initiation enzyme 3-ketoacyl acyl carrier protein synthase III (FabH) J. Bacteriol. 187 2005 3795 3799
18. H. Lu, and P.J. Tonge Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway Acc. Chem. Res. 41 2008 11 20
19. K. Makarova, A. Slesarev, Y. Wolf, A. Sorokin, B. Mirkin, E. Koonin, A. Pavlov, N. Pavlova, V. Karamychev, and N. Polouchine et al. Comparative genomics of the lactic acid bacteria Proc. Natl. Acad. Sci. USA 103 2006 15611 15616
20. C.G. Marshall, G. Broadhead, B.K. Leskiw, and G.D. Wright D-Ala-D-Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB Proc. Natl. Acad. Sci. USA 94 1997 6480 6483
21. E. Martens, and A.L. Demain Platensimycin and platencin: promising antibiotics for future application in human medicine J. Antibiot. 64 2011 705 710
22. K.A. McGuire, J.N. McGuire, and P. von Wettstein-Knowles Acyl carrier protein (ACP) inhibition and other differences between β-ketoacyl synthase (KAS) I and II Biochem. Soc. Trans. 28 2000 607 610
23. K.A. McGuire, M. Siggaard-Andersen, M.G. Bangera, J.G. Olsen, and P. von Wettstein-Knowles β-Ketoacyl-[acyl carrier protein] synthase I of Escherichia coli: aspects of the condensation mechanism revealed by analyses of mutations in the active site pocket Biochemistry 40 2001 9836 9845
24. R.M. Morgan-Kiss, and J.E. Cronan The Lactococcus lactis FabF fatty acid synthetic enzyme can functionally replace both the FabB and FabF proteins of Escherichia coli and the FabH protein of Lactococcus lactis Arch. Microbiol. 190 2008 427 437
25. J.B. Parsons, and C.O. Rock Is bacterial fatty acid synthesis a valid target for antibacterial drug discovery? Curr. Opin. Microbiol. 14 2011 544 549
26. J. Pootoolal, J. Neu, and G.D. Wright Glycopeptide antibiotic resistance Annu. Rev. Pharmacol. Toxicol. 42 2002 381 408
27. W.P. Revill, M.J. Bibb, A.-K. Scheu, H.J. Kieser, and D.A. Hopwood β-ketoacyl acyl carrier protein synthase III (FabH) is essential for fatty acid biosynthesis in Streptomyces coelicolor A3(2) J. Bacteriol. 183 2001 3526 3530
28. A.D. Russell Whither triclosan? J. Antimicrob. Chemother. 53 2004 693 695
29. M. Saleem, H. Hussain, I. Ahmed, T. van Ree, and K. Krohn Platensimycin and its relatives: a recent story in the struggle to develop new naturally derived antibiotics Nat. Prod. Rep. 28 2011 1534 1579
30. J. Sambrook, and D. Russel Molecular Cloning: A Laboratory Manual Third Edition 2001 Cold Spring Harbor Laboratory Press Cold Spring Harbor
31. H.C. Shen, F.X. Ding, S.B. Singh, G. Parthasarathy, S.M. Soisson, S.N. Ha, X. Chen, S. Kodali, J. Wang, and K. Dorso et al. Synthesis and biological evaluation of platensimycin analogs Bioorg. Med. Chem. Lett. 19 2009 1623 1627
32. M.J. Smanski, R.M. Peterson, S.R. Rajski, and B. Shen Engineered Streptomyces platensis strains that overproduce antibiotics platensimycin and platencin Antimicrob. Agents Chemother. 53 2009 1299 1304
33. M.J. Smanski, Z. Yu, J. Casper, S. Lin, R.M. Peterson, Y. Chen, E. Wendt-Pienkowski, S.R. Rajski, and B. Shen Dedicated ent-kaurene and ent-atiserene synthases for platensimycin and platencin biosynthesis Proc. Natl. Acad. Sci. USA 108 2011 13498 13503
34. M.J. Smanski, J. Casper, R.M. Peterson, Z. Yu, S.R. Rajski, and B. Shen Expression of the platencin biosynthetic gene cluster in heterologous hosts yielding new platencin congeners J. Nat. Prod. 75 2012 2158 2167
35. G. Taubes The bacteria fight back Science 321 2008 356 361
36. J. Wang, S.M. Soisson, K. Young, W. Shoop, S. Kodali, A. Galgoci, R. Painter, G. Parthasarathy, Y.S. Tang, and R. Cummings et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties Nature 441 2006 358 361
37. J. Wang, S. Kodali, S.H. Lee, A. Galgoci, R. Painter, K. Dorso, F. Racine, M. Motyl, L. Hernandez, and E. Tinney et al. Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties Proc. Natl. Acad. Sci. USA 104 2007 7612 7616
38. W. Wehrli Rifampin: mechanisms of action and resistance Rev. Infect. Dis. 5 Suppl 3 1983 S407 S411
39. S.W. White, J. Zheng, Y.-M. Zhang, and C.O. Rock The structural biology of type II fatty acid biosynthesis Annu. Rev. Biochem. 74 2005 791 831
40. G.D. Wright Molecular mechanisms of antibiotic resistance Chem. Commun. (Camb.) 47 2011 4055 4061
41. M. Wu, S.B. Singh, J. Wang, C.C. Chung, G. Salituro, B.V. Karanam, S.H. Lee, M. Powles, K.P. Ellsworth, and M.E. Lassman et al. Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes Proc. Natl. Acad. Sci. USA 108 2011 5378 5383
42. Z. Yu, M.J. Smanski, R.M. Peterson, K. Marchillo, D. Andes, S.R. Rajski, and B. Shen Engineering of Streptomyces platensis MA7339 for overproduction of platencin and congeners Org. Lett. 12 2010 1744 1747
43. Z. Yu, M.E. Rateb, M.J. Smanski, R.M. Peterson, and B. Shen Isolation and structural elucidation of glucoside congeners of platencin from Streptomyces platensis SB12600 J. Antibiot. 66 2013 291 294
44. C. Zhang, J. Ondeyka, K. Herath, H. Jayasuriya, Z. Guan, D.L. Zink, L. Dietrich, B. Burgess, S.N. Ha, J. Wang, and S.B. Singh Platensimycin and platencin congeners from Streptomyces platensis J. Nat. Prod. 74 2011 329 340